PIK3CA c.1528_1529delinsGC ;(p.H510A)

Variant ID: 3-178928342-CA-GC

NM_006218.2(PIK3CA):c.1528_1529delinsGC;(p.H510A)

This variant was identified in 12 publications

View GRCh38 version.




Publications:


Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.

Heliyon
Fariha, Atqiya A; Hami, Ithmam I; Tonmoy, Mahafujul Islam Quadery MIQ; Akter, Shahana S; Al Reza, Hasan H; Bahadur, Newaz Mohammed NM; Rahaman, Md Mizanur MM; Hossain, Md Shahadat MS
Publication Date: 2022-10

Variant appearance in text: PI3K: H510A
PubMed Link: 36303933
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Regulated cell death (RCD) in cancer: key pathways and targeted therapies.

Signal Transduction And Targeted Therapy
Peng, Fu F; Liao, Minru M; Qin, Rui R; Zhu, Shiou S; Peng, Cheng C; Fu, Leilei L; Chen, Yi Y; Han, Bo B
Publication Date: 2022-08-13

Variant appearance in text: PI3K: H510A
PubMed Link: 35963853
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.

Pharmaceuticals (Basel, Switzerland)
Gangwar, Shailendra Kumar SK; Kumar, Aviral A; Yap, Kenneth Chun-Hong KC; Jose, Sandra S; Parama, Dey D; Sethi, Gautam G; Kumar, Alan Prem AP; Kunnumakkara, Ajaikumar B AB
Publication Date: 2022-05-18

Variant appearance in text: PI3K: H510A
PubMed Link: 35631448
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-15-00624.pdf
View BVdb publication page



The Roles of microRNAs in Cancer Multidrug Resistance.

Cancers
Pavlíková, Lucia L; Šereš, Mário M; Breier, Albert A; Sulová, Zdena Z
Publication Date: 2022-02-21

Variant appearance in text: PI3K: H510A
PubMed Link: 35205839
Variant Present in the following documents:
  • Main text
  • cancers-14-01090.pdf
View BVdb publication page



iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research.

Genomics, Proteomics & Bioinformatics
Chen, Xiang X; Guo, Yi Y; Chen, Xin X
Publication Date: 2020-04

Variant appearance in text: PIK3CA: H510A
PubMed Link: 32916316
Variant Present in the following documents:
  • mmc3.xlsx, sheet 2
View BVdb publication page



Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis.

International Journal Of Molecular Sciences
Liu, Yu-Chin YC; Yeh, Chau-Ting CT; Lin, Kwang-Huei KH
Publication Date: 2019-10-09

Variant appearance in text: PI3K: H510A
PubMed Link: 31600974
Variant Present in the following documents:
  • Main text
View BVdb publication page



A novel mutation panel for predicting etoposide resistance in small-cell lung cancer.

Drug Design, Development And Therapy
Qiu, Zhengang Z; Lin, Anqi A; Li, Kun K; Lin, Weiyin W; Wang, Qiongyao Q; Wei, Ting T; Zhu, Weiliang W; Luo, Peng P; Zhang, Jian J
Publication Date: 2019

Variant appearance in text: PI3K: H510A
PubMed Link: 31417239
Variant Present in the following documents:
  • dddt-13-2021.pdf
View BVdb publication page



New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels.

Scientific Reports
Sadacca, Benjamin B; Hamy, Anne-Sophie AS; Laurent, Cécile C; Gestraud, Pierre P; Bonsang-Kitzis, Hélène H; Pinheiro, Alice A; Abecassis, Judith J; Neuvial, Pierre P; Reyal, Fabien F
Publication Date: 2017-11-09

Variant appearance in text: PIK3CA: H510A
PubMed Link: 29123141
Variant Present in the following documents:
  • 41598_2017_14770_MOESM1_ESM.pdf
View BVdb publication page



Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Lochmann, Timothy L TL; Floros, Konstantinos V KV; Naseri, Mitra M; Powell, Krista M KM; Cook, Wade W; March, Ryan J RJ; Stein, Giovanna T GT; Greninger, Patricia P; Maves, Yuki Kato YK; Saunders, Laura R LR; Dylla, Scott J SJ; Costa, Carlotta C; Boikos, Sosipatros A SA; Leverson, Joel D JD; Souers, Andrew J AJ; Krystal, Geoffrey W GW; Harada, Hisashi H; Benes, Cyril H CH; Faber, Anthony C AC
Publication Date: 2018-01-15

Variant appearance in text: PIK3CA: H510A
PubMed Link: 29118061
Variant Present in the following documents:
  • Main text
View BVdb publication page



Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.

Oncotarget
Allison Stewart, C C; Tong, Pan P; Cardnell, Robert J RJ; Sen, Triparna T; Li, Lerong L; Gay, Carl M CM; Masrorpour, Fatemah F; Fan, You Y; Bara, Rasha O RO; Feng, Ying Y; Ru, Yuanbin Y; Fujimoto, Junya J; Kundu, Samrat T ST; Post, Leonard E LE; Yu, Karen K; Shen, Yuqiao Y; Glisson, Bonnie S BS; Wistuba, Ignacio I; Heymach, John V JV; Gibbons, Don L DL; Wang, Jing J; Byers, Lauren Averett LA
Publication Date: 2017-04-25

Variant appearance in text: PI3K: H510A
PubMed Link: 28212573
Variant Present in the following documents:
  • oncotarget-08-28575-s001.pdf
View BVdb publication page



A Landscape of Pharmacogenomic Interactions in Cancer.

Cell
Iorio, Francesco F; Knijnenburg, Theo A TA; Vis, Daniel J DJ; Bignell, Graham R GR; Menden, Michael P MP; Schubert, Michael M; Aben, Nanne N; Gonçalves, Emanuel E; Barthorpe, Syd S; Lightfoot, Howard H; Cokelaer, Thomas T; Greninger, Patricia P; van Dyk, Ewald E; Chang, Han H; de Silva, Heshani H; Heyn, Holger H; Deng, Xianming X; Egan, Regina K RK; Liu, Qingsong Q; Mironenko, Tatiana T; Mitropoulos, Xeni X; Richardson, Laura L; Wang, Jinhua J; Zhang, Tinghu T; Moran, Sebastian S; Sayols, Sergi S; Soleimani, Maryam M; Tamborero, David D; Lopez-Bigas, Nuria N; Ross-Macdonald, Petra P; Esteller, Manel M; Gray, Nathanael S NS; Haber, Daniel A DA; Stratton, Michael R MR; Benes, Cyril H CH; Wessels, Lodewyk F A LFA; Saez-Rodriguez, Julio J; McDermott, Ultan U; Garnett, Mathew J MJ
Publication Date: 2016-07-28

Variant appearance in text: PIK3CA: H510A
PubMed Link: 27397505
Variant Present in the following documents:
  • mmc3.xlsx, sheet 3
View BVdb publication page



ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer.

Molecular Cancer Therapeutics
Zinn, Rebekah L RL; Gardner, Eric E EE; Marchionni, Luigi L; Murphy, Sara C SC; Dobromilskaya, Irina I; Hann, Christine L CL; Rudin, Charles M CM
Publication Date: 2013-06

Variant appearance in text: PI3K: H510A
PubMed Link: 23515613
Variant Present in the following documents:
  • Main text
View BVdb publication page